Thomas Lycan

1.0k total citations
69 papers, 691 citations indexed

About

Thomas Lycan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Thomas Lycan has authored 69 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 12 papers in Epidemiology. Recurrent topics in Thomas Lycan's work include Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Treatments and Mutations (16 papers) and Lung Cancer Research Studies (15 papers). Thomas Lycan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Treatments and Mutations (16 papers) and Lung Cancer Research Studies (15 papers). Thomas Lycan collaborates with scholars based in United States. Thomas Lycan's co-authors include Jimmy Ruiz, W. Jeffrey Petty, Tamjeed Ahmed, Ümit Topaloĝlu, Michael D. Chan, Lawrence J. Cheskin, Lisa Davis, Michael Farris, Beverly J. Levine and Stefan C. Grant and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Lycan

59 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Lycan United States 15 317 228 169 96 81 69 691
Krzysztof Krzemieniecki Poland 14 412 1.3× 253 1.1× 130 0.8× 35 0.4× 101 1.2× 58 801
Anna Compagnoni Italy 13 351 1.1× 207 0.9× 180 1.1× 45 0.5× 109 1.3× 19 840
Feyyaz Özdemir Türkiye 13 217 0.7× 97 0.4× 118 0.7× 30 0.3× 44 0.5× 76 587
Visalini Nair‐Shalliker Australia 15 128 0.4× 107 0.5× 185 1.1× 65 0.7× 89 1.1× 29 659
Mathew Vithayathil United Kingdom 18 240 0.8× 146 0.6× 219 1.3× 68 0.7× 123 1.5× 45 963
So Yeon Kim United States 8 282 0.9× 271 1.2× 258 1.5× 56 0.6× 94 1.2× 21 771
Loredana Santo United States 16 582 1.8× 155 0.7× 510 3.0× 47 0.5× 43 0.5× 39 1.2k
Martin Vogelhuber Germany 16 288 0.9× 85 0.4× 158 0.9× 75 0.8× 17 0.2× 50 600
Christina L. Costantino United States 15 282 0.9× 147 0.6× 332 2.0× 50 0.5× 58 0.7× 26 876
Xueqing Hu China 11 131 0.4× 119 0.5× 154 0.9× 61 0.6× 34 0.4× 33 509

Countries citing papers authored by Thomas Lycan

Since Specialization
Citations

This map shows the geographic impact of Thomas Lycan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lycan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lycan more than expected).

Fields of papers citing papers by Thomas Lycan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lycan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lycan. The network helps show where Thomas Lycan may publish in the future.

Co-authorship network of co-authors of Thomas Lycan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lycan. A scholar is included among the top collaborators of Thomas Lycan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lycan. Thomas Lycan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lycan, Thomas, D. Norton, & Jill Ohar. (2024). COPD and Immune Checkpoint Inhibitors for Cancer: A Literature Review. International Journal of COPD. Volume 19. 2689–2703. 3 indexed citations
3.
Olson, Eric R., et al.. (2024). Immune-Related Adverse Events of Genitourinary Cancer Patients, a Retrospective Cohort Study. Cancers. 16(17). 3045–3045. 2 indexed citations
4.
D’Agostino, Ralph B., Jimmy Ruiz, Lance D. Miller, et al.. (2024). Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer. Cancer Research. 84(23). 4002–4016. 4 indexed citations
5.
Song, Alexander H., Thomas Lycan, Rebecca L. Kinney, et al.. (2024). Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic Advances in Medical Oncology. 16. 2662695–2662695. 1 indexed citations
6.
Wang, Yuezhu, Ralph B. D’Agostino, Jimmy Ruiz, et al.. (2024). IASLC grading system predicts distant metastases for resected lung adenocarcinoma. Journal of Clinical Pathology. 78(6). 409–415. 1 indexed citations
7.
D’Agostino, Ralph B., Steven E. Glynn, M. D. Smith, et al.. (2024). Genomic Signature for Leptomeningeal Progression in Brain Metastasis Patients Using Liquid Biopsy-Acquired Comprehensive Genomic Profiling. International Journal of Radiation Oncology*Biology*Physics. 120(2). S190–S191.
8.
Hughes, Ryan T., Beverly J. Levine, Bart Frizzell, et al.. (2024). Keratin-based topical cream for radiation dermatitis during head and neck radiotherapy: a randomised, open-label pilot study. Journal of Radiotherapy in Practice. 23. 2 indexed citations
9.
McLouth, Laurie E., Jennifer Gabbard, Beverly J. Levine, et al.. (2023). Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer. Journal of Palliative Medicine. 26(6). 831–836. 10 indexed citations
10.
Hughes, Ryan T., Beverly J. Levine, Kathryn M. Greven, et al.. (2023). Feasibility of a Keratin-Based Topical Cream for Radiation Dermatitis in Patients with Head and Neck Cancer: Results of a Randomized Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). e590–e590. 1 indexed citations
11.
Wang, Yuezhu, Ralph B. D’Agostino, Jimmy Ruiz, et al.. (2023). c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities. Cancers. 15(9). 2626–2626. 13 indexed citations
12.
Farris, Joshua C., Paul Black, Michael D. Chan, et al.. (2022). Intensity‐modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures. Head & Neck. 44(11). 2571–2578. 5 indexed citations
13.
Xie, Amy, Alexander H. Song, Ryan T. Hughes, et al.. (2021). Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Cancers. 13(22). 5733–5733. 25 indexed citations
14.
Lycan, Thomas, et al.. (2021). P48.01 Gemcitabine and Nivolumab for Subsequent Treatment of Metastatic Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S499–S499. 3 indexed citations
15.
Williams, Donna M., et al.. (2021). Just-in-Time Teaching (JiTT) Screencasts: a Randomized Controlled Trial of Asynchronous Learning on an Inpatient Hematology-Oncology Teaching Service. Journal of Cancer Education. 37(6). 1711–1718. 1 indexed citations
16.
Wu, Shih-Ying, Fei Xing, Sambad Sharma, et al.. (2020). Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function. The Journal of Experimental Medicine. 217(8). 77 indexed citations
17.
Rhoads, Anthony, Alexandra Thomas, Joseph Aloi, et al.. (2020). Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER 18 2000–2016. Thyroid. 30(12). 1781–1791. 9 indexed citations
18.
Ahmed, Tamjeed, et al.. (2019). P2.04-93 Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S746–S747. 1 indexed citations
19.
Roberts, Nathan B., et al.. (2019). OA01.04 Safety and Efficacy of Flu Vaccination After Treatment with Immune Checkpoint Inhibitors: a Retrospective Review. Journal of Thoracic Oncology. 14(11). S1125–S1125. 3 indexed citations
20.
Lycan, Thomas, et al.. (2015). Impact of Curriculum Content on Resident Attitudes Towards Cancer Care. Journal of Cancer Education. 32(2). 280–282. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krzysztof Krzemieniecki Breakdown of academic impact, for papers by Anna Compagnoni Breakdown of academic impact, for papers by Feyyaz Özdemir Breakdown of academic impact, for papers by Visalini Nair‐Shalliker Breakdown of academic impact, for papers by Mathew Vithayathil Breakdown of academic impact, for papers by So Yeon Kim Breakdown of academic impact, for papers by Loredana Santo Breakdown of academic impact, for papers by Martin Vogelhuber Breakdown of academic impact, for papers by Christina L. Costantino Breakdown of academic impact, for papers by Xueqing Hu
Rankless by CCL
2026